Monte Rosa Therapeutics, Inc. (GLUE)
14.10
-0.22
(-1.54%)
USD |
NASDAQ |
Sep 11, 16:00
14.10
0.00 (0.00%)
After-Hours: 18:34
Monte Rosa Therapeutics Gross Profit (TTM) : 20.60M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.60M |
| March 31, 2026 | 34.62M |
| December 31, 2025 | 115.32M |
| September 30, 2025 | 173.21M |
| June 30, 2025 | 169.65M |
| March 31, 2025 | 151.22M |
| December 31, 2024 | 67.50M |
| September 30, 2024 | 7.069M |
| June 30, 2024 | -1.878M |
| March 31, 2024 | -5.904M |
| December 31, 2023 | -6.222M |
| September 30, 2023 | -7.058M |
| June 30, 2023 | -7.80M |
| Date | Value |
|---|---|
| March 31, 2023 | -8.578M |
| December 31, 2022 | -8.559M |
| September 30, 2022 | -6.686M |
| June 30, 2022 | -4.692M |
| March 31, 2022 | -2.99M |
| December 31, 2021 | -2.132M |
| September 30, 2021 | -1.546M |
| June 30, 2021 | -1.135M |
| March 31, 2021 | -0.74M |
| December 31, 2020 | -0.537M |
| September 30, 2020 | -0.314M |
| June 30, 2020 | -0.143M |
| March 31, 2020 | -0.071M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Nurix Therapeutics, Inc. | 19.51M |
| Gilead Sciences, Inc. | 24.33B |
| Ironwood Pharmaceuticals, Inc. | 387.48M |
| Capricor Therapeutics, Inc. | -2.095M |
| Cue Biopharma, Inc. | 37.39M |